-
1دورية أكاديمية
المؤلفون: Bailly C; INSERM U-524, Centre Oscar Lambert, Lille, France. bailly@lille.inserm.fr, Dassonneville L, Carrasco C, Lucas D, Kumar A, Boykin DW, Wilson WD
المصدر: Anti-cancer drug design [Anticancer Drug Des] 1999 Feb; Vol. 14 (1), pp. 47-60.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 8603523 Publication Model: Print Cited Medium: Print ISSN: 0266-9536 (Print) Linking ISSN: 02669536 NLM ISO Abbreviation: Anticancer Drug Des Subsets: MEDLINE
مواضيع طبية MeSH: Topoisomerase II Inhibitors*, Anti-Bacterial Agents/*pharmacology , Antineoplastic Agents/*pharmacology , Enzyme Inhibitors/*pharmacology , Furans/*pharmacology, Anti-Bacterial Agents/chemistry ; Anti-Bacterial Agents/metabolism ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/metabolism ; Binding Sites ; DNA Footprinting ; DNA Topoisomerases, Type I/chemistry ; DNA Topoisomerases, Type II/chemistry ; DNA, Bacterial/metabolism ; DNA, Superhelical/chemistry ; Electrophoresis, Polyacrylamide Gel ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/metabolism ; Escherichia coli/metabolism ; Furans/chemistry ; Furans/metabolism ; Humans ; Indicators and Reagents ; Potassium Permanganate
-
2دورية أكاديمية
المؤلفون: Wilson WD; Department of Chemistry, Georgia State University, Atlanta 30303., Tanious FA, Barton HJ, Wydra RL, Jones RL, Boykin DW, Strekowski L
المصدر: Anti-cancer drug design [Anticancer Drug Des] 1990 Feb; Vol. 5 (1), pp. 31-42.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 8603523 Publication Model: Print Cited Medium: Print ISSN: 0266-9536 (Print) Linking ISSN: 02669536 NLM ISO Abbreviation: Anticancer Drug Des Subsets: MEDLINE
مواضيع طبية MeSH: Bleomycin/*metabolism , DNA/*metabolism , Heterocyclic Compounds/*metabolism , Intercalating Agents/*metabolism, Base Sequence ; Binding Sites ; Bleomycin/pharmacology ; Drug Design ; Drug Interactions ; Models, Molecular ; Structure-Activity Relationship